Metformin inhibits human non-small cell lung cancer by regulating AMPK-CEBPB-PDL1 signaling pathway.
Lu T, Li M, Zhao M, Huang Y, Bi G, Liang J, Chen Z, Zheng Y, Xi J, Lin Z, Zhan C, Jiang W, Wang Q, Tan L.
Lu T, et al. Among authors: jiang w.
Cancer Immunol Immunother. 2022 Jul;71(7):1733-1746. doi: 10.1007/s00262-021-03116-x. Epub 2021 Nov 27.
Cancer Immunol Immunother. 2022.
PMID: 34837101
Free PMC article.